INCY vs IQV
Incyte Corp (INCY) and Iqvia Holdings Inc. (IQV) are both filed with the SEC under Services-Commercial Physical & Biological Research. IQV is 1.7× INCY's size by market cap ($43.8B against $25.5B); IQV trades at the higher fiscal-year P/E (33.5× against 19.9×); INCY reports the higher net margin (25.0% against 8.3%); INCY grew sales faster over three years (+14.8% against +4.2%); and over the past year INCY returned +48.6% against IQV's +38.7%.
| INCY | IQV | |
|---|---|---|
| Last close | $124.37 | $261.75 |
| Market cap | $25.5B | $43.8B |
| P/E (FY) | 19.9× | 33.5× |
| P/S | 5.0× | 2.7× |
| EV/EBITDA | — | 17.3× |
| Operating margin | 29.5% | 13.4% |
| Net margin | 25.0% | 8.3% |
| Return on equity | 29.9% | 21.6% |
| Sales growth (3y) | +14.8% | +4.2% |
| EPS growth (3y) | +61.6% | +11.1% |
| 1-year return | +48.6% | +38.7% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year — FY2025 (ended 2025-12-31) for both. — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| INCY | IQV | |
|---|---|---|
| Institutional holders (13F) | 809 | 1,062 |
| Insider buyers − sellers (180d) | -3 | — |
| Congressional trades disclosed (180d) | 0 | 1 |
| Executive-branch officials on file — trades disclosed (180d) | 0 | 8 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5. — no open-market Form 4 purchases or sales in the window.
INCY vs IQV: common questions
- Is INCY bigger than IQV?
- IQV carries the larger market cap — $43.8B against $25.5B, both struck on 2026-08-27.
- Which trades at a higher P/E, INCY or IQV?
- IQV, at a fiscal-year 33.5× against 19.9× for INCY. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have INCY and IQV performed over the past year?
- INCY returned +48.6% and IQV +38.7%, measured on the trailing calendar year to the last close.
- How many institutions hold INCY and IQV?
- 809 13F filers report a position in INCY and 1,062 in IQV, on the latest quarter in the panel.
- Are INCY and IQV in the same industry?
- Both are filed with the SEC under Services-Commercial Physical & Biological Research, which is the classification this pairing is built on.
INCY overview → · IQV overview → · INCY institutional ownership → · IQV institutional ownership → · Congress and IQV → · Executive branch and IQV →
More in Services-Commercial Physical & Biological Research: INCY vs MEDP · IQV vs MEDP
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/incy-vs-iqv